title: Evaluation of potential antidotes for sodium fluoroacetate in mice.
abstract: Pathogenesis in fluoroacetate poisoning is multifactorial. Biochemically it is characterized by lethal synthesis of fluorocitrate, causing hypocalcemia, and energy deficiency through blockade of the TCA cycle. Calcium gluconate (CaG) was chosen to antagonize hypocalcemia, while sodium alpha kelogluterate (NaKG) and sodium succinate (NaSuc) were selected as potential antidotes to revive the TCA cycle. Effectiveness of each of these antidotes individually and in certain combinations was tested in mice exposed to lethal doses (15 mg/kg ip) of sodium fluoroacetate (NaFAC). Antidotal treatments were administered at 15 min, 4 h, 10 h, 24 h, and 36 h after NaFAC. All 3 of the antidotes alone, as well as a combination of CaG with NaKG, were ineffective in reducing mortality in mice after NaFAC. On the other hand, a combination of CaG (130 mg/kg) with NaSuc (240 mg/kg) was effective if the 2 solutions were either injected at separate sites or mixed in the same syringe just prior to injection. Similar solutions, if mixed for 24 h or longer before administrations, were ineffective. Increasing the dose of NaSuc to 360 or 480 mg/kg with CaG (130 mg/kg) was unrewarding. These results indicate that CaG in combination with 240 mg NaSuc/kg offer a promising therapy modality in NaFAC intoxication. Additional studies involving biochemical parameters and other species are needed to confirm the efficacy and mechanism(s) of action of this combination.
authors.affiliation: Department of Veterinary Physiological Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada.
authors.forename: F
authors.initials: F
authors.lastname: Omara
authors.forename: C S
authors.initials: CS
authors.lastname: Sisodia
mesh_terms: D000818:Animals; D000931:Antidotes / Q000494:pharmacology* / Q000627:therapeutic use; D002125:Calcium Gluconate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005463:Fluoroacetates / Q000008:administration & dosage / Q000506:poisoning*; D006996:Hypocalcemia / Q000139:chemically induced / Q000188:drug therapy; D007274:Injections, Intraperitoneal; D007656:Ketoglutaric Acids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D012378:Rodenticides / Q000506:poisoning*; D013386:Succinates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D019802:Succinic Acid
chemical_list: D000931:Antidotes; D005463:Fluoroacetates; D007656:Ketoglutaric Acids; D012378:Rodenticides; D013386:Succinates; D019802:Succinic Acid; C014815:fluoroacetic acid; D002125:Calcium Gluconate